Antifibrotic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure

Heart failure (HF) is an urgent public health problem worldwide. A fundamental role in HF progression is played by fibrosis, which causes structural myocardial and vascular changes. In this regard, it seems relevant to search for pathogenetically justified HF therapy, aimed at slowing the myocardial...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. S. Ignatova, S. U. Shuster, T. B. Pecherina, O. L. Barbarash
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2024-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5580
Tags: Add Tag
No Tags, Be the first to tag this record!